go to main content

Innovation requires collaboration

Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.

 

read more

What we do

collaboration
opportunities
contact
news
spin-off companies
licensing opportunities
our collaborations

News

setup e-mail alert

Radboudumc Investment Day 2022

26 September 2022

Get ready for Radboudumc Investment Day 2022: October 5 in Nijmegen!

Innovation by Predica Diagnostics BV improves cervical cancer screening

26 July 2022

A joint financing round from ION+2 and the Thematic Technology Transfer Medtech Fund (TTT Medtech) allows the further development of molecular diagnostic tests for different cancers by Predica Diagnostics (Nijmegen, NL).

Xenikos enrolls first patient in global pivotal phase 3 study evaluating T-Guard®

30 June 2022 First patient dosed in their Phase 3 study for T-Guard, a candidate for the treatment of severe acute graft-versus-host disease (aGVHD).

Radboudumc and Terumo Europe N.V. sign collaboration agreement

3 June 2022 Together, the two partners will improve existing treatments for cancer patients and develop new, personalized therapies. Focus will be on the clinical use of holmium-166 microspheres, small radioactive beads.

Simmunext: where immunotherapy and chemistry meet

2 June 2022 The story behind Radboud university medical center’s, Radboud University’s and Oncode’s newest spinoff, Simmunext Biotherapeutics B.V.

Setup e-mail alerts

We've succesfully saved your e-mail alert
Something went wrong!
Something went wrong while requesting this page. Please try again.
Email address *

  • Would you like to receive e-mail updates?

    Select the frequency of how often you would like to receive an e-mail alert

Follow us